| | Per 2027 Note | | | Per 2029 Note | | | Per 2034 Note | |
Public offering price | | | 100.000%(2) | | | 100.000%(2) | | | 99.896%(2) |
Total | | | $750,000,000 | | | $750,000,000 | | | $499,480,000 |
Underwriting discount(1) | | | $1,875,000 | | | $2,625,000 | | | $2,250,000 |
Proceeds before expenses, to the Issuer | | | $748,125,000 | | | $747,375,000 | | | $497,230,000 |
(1) | The underwriting discount is 0.250% of the principal amount of the 2027 Notes, 0.350% of the principal amount of the 2029 Notes and 0.450% of the 2034 Notes. We refer to “Underwriting” beginning on page S-101 of this prospectus supplement for additional information regarding underwriting compensation. |
(2) | Plus accrued interest, if any, on the Notes from May 8, 2024. |
Joint Book-Running Managers | ||||||||||||
| | | | | | | | |||||
Citigroup | | | HSBC | | | J.P. Morgan | | | Morgan Stanley | | | Santander |